Remove 2026 Remove Compounding Remove Dosage
article thumbnail

Biopharmaceutical bioseparation systems market to value $20bn

European Pharmaceutical Review

billion by 2026, achieving a compound annual growth rate (CAGR) of 13.2 percent CAGR between 2022 and 2026. According to recent market research , the global market for biopharmaceutical bioseparation systems, estimated to value $13 billion in 2022, is projected to grow to $19.6

Dosage 111
article thumbnail

Handling HPAPIs safely – what does it take?

European Pharmaceutical Review

” Highly potent APIs are pharmacologically and biologically active compounds at low doses. The compounds require special handling due to their cytotoxicity in the NCEs and investigational new drug applications (INDs). Managing highly potent cytotoxic compounds in early phases and at a late stage is a complex process.

article thumbnail

Top Performing Drug of 2021 - Trulicity (February Edition)

PharmaShots

Active Ingredient: dulaglutide Dosage Forms & Strengths: Injection: 0.75 In the US, Trulicity is protected by a compound patent (2027) and by biologics data protection (2026). mL, 3 mg/0.5 Hence, it needs to protect its patent as Trulicity patents are very vital to the company’s business as a whole.